Clinical Trial Update: Omics Gaucher Study: Multiomic Approach

View source ↗

Summary

A multiomic study on Gaucher disease led by CENTOGENE is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Snippet

Sponsor: CENTOGENE GmbH Rostock | Conditions: Gaucher Disease | Status: ACTIVE_NOT_RECRUITING